Lack of susceptibility of the cottontop tamarin to hepatitis C infection

Journal of Medical Virology

Volumn 52, Issue 3, 1997, Pages 286-288

  Garson, Jeremy A ^a   Whitby, Kevin ^a   Watkins, Paul ^b   Morgan, Andrew J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Animal model; Cottontop tamarin; Hepatitis C virus; Inoculation; PCR

Indexed keywords

VIRUS RNA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; INFECTION SENSITIVITY; INOCULATION; MALE; MONKEY; NONHUMAN; POLYMERASE CHAIN REACTION;

ANIMALS; BILIRUBIN; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MONKEY DISEASES; RNA, VIRAL; SAGUINUS;

ANIMALIA; HEPATITIS C VIRUS; PAN TROGLODYTES; PRIMATES; SAGUINUS IMPERATOR;

EID: 0030787907     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199707)52:3<286::AID-JMV9>3.0.CO;2-Z     Document Type: Article

References (9)

1. Abe K, Kurata T, Teramoto Y, Shiga J, Shikata T (1993): Lack of susceptibility of various primates and woodchucks to hepatitis C virus. Journal of Medical Primatology 22:433-434.
2. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N (1992): Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
3. Finerty S, Tarlton J, Mackett M, Conway M, Arrand JR, Watkins PE, Morgan AJ (1992): Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector. Journal of Genernal Virology 73:449-453.
4. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle J, Melpolder JJ, Alter HJ (1991): Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 14:969-974.
5. Morgan AJ (1996): Vaccination against Epstein-Barr virus infection. In Barbanti-Brodano G, Bendinelli M, Friedman, H (eds): "DNA Tumour Viruses: Oncogenic Mechanisms." New York: Plenum Press, pp 395-419.
6. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Applications to clinical surveys and tracing infectious sources. Journal of General Virology 73:673-679.
7. Tabor E (1989): Non human primate models for non-A, non-B hepatitis. Cancer Detection and Prevention 144:221-225.
8. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T (1993): Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England Journal of Medicine 328: 1797-1801.
9. Whitby K, Garson JA (1995): Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. Journal of Virology Methods 51:75-88.